Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-14

Clinical Trial Update: Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pexiganan vs placebo for mild diabetic foot infections; results have been posted after completion of the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pexiganan (pexiganan)

Snippet

Sponsor: Dipexium Pharmaceuticals, Inc. | Conditions: Diabetic Foot Infection | Phase 3 | Status: COMPLETED | Results posted: 2017-06-14